Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Michael E. Glasscock"'
Autor:
Brian M. Spearman, Anna McCraney, Michael R. Spearman, C. Y. Joseph Chang, Michael E. Glasscock
Publikováno v:
Otology & Neurotology. 38:1308-1314
OBJECTIVE To report the results of patients with the Maxum middle ear implant (MEI) and compare word recognition scores (WRS) and speech perception gap (SP Gap) of Maxum versus optimally fit hearing aids (HA). STUDY DESIGN Case series with chart revi
Publikováno v:
The Laryngoscope. 126:2124-2127
Objectives/Hypothesis To report the preliminary results of the Ototronix MAXUM middle ear implant for treatment of severe high-frequency sensorineural hearing loss. Study Design Case series with chart review. Methods Six consecutive ears with severe
Publikováno v:
Operative Techniques in Otolaryngology-Head and Neck Surgery. 25:338-343
For many individuals with hearing impairment, the benefits of hearing aids may be reduced by acoustic feedback, occlusion effect, difficult fitting, and recurrent ear canal irritation. Additionally, many hearing aid candidates refuse use because of c
Autor:
Michael E. Glasscock, David S. Haynes, Matthew L. Carlson, Julie Daugherty, Charissa N. Kahue
Publikováno v:
Otology & Neurotology. 35:1228-1237
OBJECTIVE: To systematically review the safety and efficacy of the 3 Food and Drug Administration-approved middle ear implant (MEI) systems currently in use for the rehabilitation of sensorineural hearing loss. DATA SOURCES: MEDLINE and Cochrane Libr
Autor:
Alejandro Rivas, Richard F. Latuska, George B. Wanna, Michael E. Glasscock, Stanley Pelosi, Marc L. Bennett, David S. Haynes, Matthew L. Carlson
Publikováno v:
Otology & Neurotology. 35:84-90
Objective To describe a contemporary, pragmatic approach to managing cholesteatoma in the only hearing ear. Study design Retrospective case series. Setting Single tertiary referral center. Patients All patients that underwent cholesteatoma surgery, h
Publikováno v:
The Laryngoscope. 126(9)
To report the preliminary results of the Ototronix MAXUM middle ear implant for treatment of severe high-frequency sensorineural hearing loss.Case series with chart review.Six consecutive ears with severe high-frequency sensorineural hearing loss (
Publikováno v:
The Laryngoscope. 114:506-511
Mastoidectomy has long been identified as an effective method of treatment for chronic ear infection. The effect of mastoidectomy on patients without evidence of active infectious disease remains highly debated and unproven. The objective in the stud
Autor:
Michael E. Glasscock
Publikováno v:
Otolaryngologic Clinics of North America. 35:227-238
I realize I practiced otology and neuro-otology during a golden era, but I have to admit that I didn't appreciate how important it was until I sat down to outline this article. How fortunate I was to have lived and practiced during these developing y
Autor:
Alex D. Sweeney, David S. Haynes, Michael E. Glasscock, George B. Wanna, Stanley Pelosi, Matthew L. Carlson
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 152(1)
To characterize the clinical presentation, surgical management, and outcomes of a large consecutive cohort of patients with glomus tympanicum (GT) tumors managed at a single tertiary referral group over 4 decades.Retrospective review.Tertiary neuroto
Publikováno v:
Otolaryngologic clinics of North America. 47(6)
For many hearing-impaired individuals, the benefits of conventional amplification may be limited by acoustic feedback, occlusion effect, and/or ear discomfort. The MAXUM system and other implantable hearing devices have been developed as an option fo